Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHICL Infrastructure Regulatory News (HICL)

Share Price Information for HICL Infrastructure (HICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 123.40
Bid: 118.40
Ask: 137.00
Change: 0.00 (0.00%)
Spread: 18.60 (15.709%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 123.40
HICL Live PriceLast checked at -
HICL Infrastructure is an Investment Trust

To deliver a long-term, stable income to shareholders from a diversified portfolio of infrastructure investments positioned at the lower end of the risk spectrum.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Intention to undertake equity fundraising

31 Jan 2013 10:30

RNS Number : 7911W
HICL Infrastructure Company Ld
31 January 2013
 



HICL Infrastructure Company Limited (the "Company")

 

31 January 2013

 

Intention to undertake equity fundraising

 

The Board of HICL Infrastructure Company Limited is pleased to announce that it intends to proceed with a Placing, Open Offer and Offer for Subscription of Ordinary Shares (the "Issue") during the first quarter of this year.

 

In the Company's announcement of 17 December 2012, it was noted that the Company's ability to issue shares by way of 'tap' has been fully utilised for the time being, and that any further issue of shares on a non-pre-emptive basis would only be permitted following the requisite grant of authority by shareholders at a general meeting of the Company. The pipeline of potential new business remains healthy, and the Company's Investment Adviser is confident that further attractive investment opportunities will arise in the coming months. In light of the Group's current funding requirement of approximately £30m, and in anticipation of further investments being made, it is now the Board's intention to publish a prospectus in relation to the Issue, and to convene a general meeting for the purposes of seeking shareholder approval for the Issue.

 

As with previous formal equity fundraisings by the Company, the inclusion of an Open Offer will ensure that a portion of the Issue is reserved in the first instance exclusively for existing shareholders. Further details as to the precise timing and quantum of the Issue will be announced in due course. For indicative purposes, however, it is envisaged that a prospectus will be published in February, and that (subject to shareholder approval) the new Ordinary Shares will be issued and commence trading by the end of March. In terms of the size of the Issue, the Board will continue to observe the policy that the Company should not be cash positive to any material extent, and accordingly the Issue will be limited in size to the aggregate of (i) the Group's funding requirements at the time of publication of the prospectus and (ii) the consideration payable for further investments made or expected to be made by the Group (whether on a conditional or unconditional basis).

 

The Company has typically declared a second interim dividend in April or May of each year. In order to uphold the integrity of the cash cover on the Company's dividend, it is proposed that the record date in respect of the second interim dividend for the financial year ended 31 March 2013 should be brought forward ahead of the date of publication of the prospectus. Accordingly, subscribers for the new Ordinary Shares will not be entitled to this second interim dividend.

 

A further announcement giving full details of the Issue will be made at the time of publication of the prospectus.

 

 

Enquiries:

InfraRed Capital Partners Limited
020 7484 1800
Tony Roper
 
Keith Pickard
 
Erwan Fournis
 
Robin Hubbard
 
David Foot
 
 
 
Canaccord Genuity Limited
 
Sales Enquiries
 
Dominic Waters
020 7523 8473
Neil Brierley
020 7523 8478
Will Barnett
020 7523 8094
Robbie Robertson
020 7523 8474
Gavin Tooke
020 7523 8470
 
 
Corporate Enquiries
 
David Yovichic
020 7523 8361
Lucy Lewis
020 7523 8360
 
 
Tulchan Communications
020 7353 4200
Ed Orlebar
 
Rebecca Scott
 
 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUAOKRONAAORR
Date   Source Headline
11th Jun 20185:30 pmRNSAnnual Financial Report
11th Jun 20187:00 amRNSIncremental Acquisition
1st Jun 201811:01 amRNSScrip Dividend Alternative - Suspension
30th May 20188:31 amRNSDirector/PDMR Shareholding
29th May 20184:00 pmRNSDirector/PDMR Shareholding
25th May 201810:00 amRNSEU GDPR Data Privacy Notices
23rd May 20187:00 amRNSAnnual Financial Report
16th May 20182:00 pmRNSFourth Quarterly Interim Dividend
30th Apr 20187:00 amRNSDisposal of an investment
27th Apr 20187:00 amRNSNew Investments
17th Apr 20183:13 pmRNSDirector Declaration
17th Apr 201810:02 amRNSDirectorate Change
16th Apr 20187:25 amRNSNotice of Annual Results
16th Apr 20187:25 amRNSNew Investment
5th Apr 20183:00 pmRNSDirector/PDMR Shareholding
29th Mar 201812:00 pmRNSTotal Voting Rights
26th Mar 20185:00 pmRNSDirector/PDMR Shareholding
26th Mar 20185:00 pmRNSDirector/PDMR Shareholding
26th Mar 20185:00 pmRNSDirector/PDMR Shareholding
26th Mar 201812:00 pmRNSAdditional Listing
26th Mar 20187:00 amRNSIncremental Investment
21st Mar 20185:02 pmRNSDirector/PDMR Shareholding
19th Mar 20182:43 pmRNSDirector Declaration
8th Mar 20185:30 pmRNSScrip Share Reference Price
2nd Mar 20182:00 pmRNSDirector/PDMR Shareholding
21st Feb 201812:52 pmRNSThird Quarterly Interim Dividend
7th Feb 201811:36 amRNSCapital Markets Seminar
5th Feb 20187:00 amRNSInterim Update Statement
1st Feb 20187:00 amRNSRenewal of the Group's Revolving Credit Facility
30th Jan 20188:00 amRNSDirector/PDMR Shareholding
29th Jan 20185:05 pmRNSDirector/PDMR Shareholding
29th Jan 20182:20 pmRNSDirector/PDMR Shareholding
29th Jan 20182:19 pmRNSDirector/PDMR Shareholding
26th Jan 20185:12 pmRNSDirector/PDMR Shareholding
26th Jan 20185:10 pmRNSDirector/PDMR Shareholding
26th Jan 20183:54 pmRNSDirector/PDMR Shareholding
26th Jan 20183:53 pmRNSDirector/PDMR Shareholding
26th Jan 20187:00 amRNSUpdate on Service Provision
15th Jan 20188:55 amRNSService Provision Continuity
3rd Jan 20183:00 pmRNSDirector/PDMR Shareholding
29th Dec 20171:30 pmRNSTotal Voting Rights
22nd Dec 201710:22 amRNSAdditional Listing
21st Dec 20175:00 pmRNSPublication of Interim Report
20th Dec 201711:00 amRNSKey Information Document
30th Nov 20173:00 pmRNSScrip Share Reference Price
27th Nov 20177:00 amRNSDirector/PDMR Shareholding
22nd Nov 20177:00 amRNSInterim Results Six Months Ended 30 September 2017
16th Nov 20177:00 amRNSSecond Quarterly Interim Dividend
4th Oct 20177:00 amRNSDirector/PDMR Shareholding 30 September 2017
29th Sep 20173:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.